Cargando…
1996. Addressing Pulmonary Nocardiosis Risk in Immunocompromised Patients: Development and Validation of a Commercially Available PCR
BACKGROUND: Pulmonary nocardiosis is an infection targeting immunocompromised patients characterized by high mortality and requires nonfrontline antibiotics for treatment. Nocardiosis is currently confirmed or excluded by BAL fluid culture followed by further phenotypic identification steps. A cultu...
Autores principales: | Smith, Emily, Bartlett, Katelyn, Grantham, James, Powell, Natalie, Altrich, Michelle, Kleiboeker, Steve, Wissel, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253286/ http://dx.doi.org/10.1093/ofid/ofy210.1652 |
Ejemplares similares
-
1786. An Automated Method to Assess Oligonucleotide Primer and Probe Complementarity to Genomic Targets in Infectious Disease qPCR Assays
por: Sinha, Rohita, et al.
Publicado: (2019) -
648. Baloxavir Resistance: qPCR Detection of Antiviral Resistance Markers in Influenza A Virus
por: Tyler, Aaron J, et al.
Publicado: (2019) -
2038. Invasive Mucormycosis Management: Mucorales PCR Provides Important, Novel Diagnostic Information
por: Wilgers, Kyle, et al.
Publicado: (2018) -
2296. Development of a Sequencing-Based Assay for Detection of CMV Antiviral Resistance Mutations to Letermovir in UL56
por: Grantham, James, et al.
Publicado: (2018) -
Detection of Cytomegalovirus (CMV) in Saliva of Congenitally Infected Neonates
por: Wissel, Mark, et al.
Publicado: (2017)